ESG Data

Environment

Greenhouse Gas Emissions (Own Emissions)

Unit FY2022 FY2023 FY2024
Scope1 t-CO2 28,439 31,081 31,208
Scope2(location-based)* t-CO2 - - 48,649
Scope2(market-based) t-CO2 46,522 42,494 40,518
Scope1+Scope2
(market-based) total		 t-CO2 74,991 73,575 71,726

* Publicly disclosed from FY2024

Calculated based on data from MEDIPAL HOLDINGS CORPORATION and consolidated subsidiaries

Greenhouse Gas Emissions (Scope3)*1

Unit FY2022*2 FY2023 FY2024
Category 2: Capital goods t-CO2 60,401 72,953 50,714
Category 3: Fuel-and energy-related activities (not included in scope 1 or scope 2) t-CO2 17,304 14,990 15,140
Category 4: Upstream transportation and distribution t-CO2 110,073 68,622 82,129
Category 5: Waste generated in operations t-CO2 826 1,202 1,238
Category 6: Business travel t-CO2 1,572 1,176 1,048
Category 7: Employee commuting t-CO2 23,268 41,858 24,383
Category 13: Downstream leased assets t-CO2 2,728 2,106 7,285
Category 15: Investments t-CO2 12,601 16,743 3,442

Calculated following materials
a) Basic guidelines for accounting for greenhouse gas emissions throughout the supply chain ver.2.7 (Ministry of the environment, Ministry of Economy, Trade and Industry)
b) Emission intensity database for calculating greenhouse gas emissions, etc. of an organization through the supply chain ver.3.5 (Ministry of the environment, Ministry of Economy, Trade and Industry)
c) LCI data base IDEAv2 (Sustainable Management Promotion Organization)

  • *1 We are in the process of carefully examining other categories to increase the accuracy of calculations.
  • *2 Implemented at
    MEDIPAL HOLDINGS CORPORATION,
    MEDICEO CORPORATION,
    EVERLTH Co., Ltd.,
    ATOL CO., LTD.,
    MM CORPORATION,
    PALTAC CORPORATION,
    MP AGRO CO., LTD.,
    and MEDIPAL FOODS CORPORATION
Calculated based on data from MEDIPAL HOLDINGS CORPORATION and consolidated subsidiaries

Energy usage

Unit FY2022 FY2023 FY2024
Fuel Gasoline kL 10,415 11,927 11,802
Diesel oil kL 914 858 1,012
Kerosene kL 39 72 78
Class A heavy oil kL 327 146 145
LP gas t 9 9 8
City gas Nm3 392,000 404,000 441,000
Electricity kWh 110,507,000 113,913,000 115,357,000
Of which renewable energy kWh 3,144,000 16,490,000 22,452,000
Proportion % 2.8 14.5 19.5
  • Calculated based on data from MEDIPAL HOLDINGS CORPORATION and consolidated subsidiaries

Social

Unit FY2022*2 FY2023 FY2024
Managerial roles filled by women rate*1 % 7.9 8.5 9.4
Employees with disabilities rate*1 % 2.54 2.66 2.76
Male employees taking childcare leave rate % 20.1 48.1 58.9
Paid Leave Usage rate % 58.2 56.8 65.4
Overtime Work (Monthly Average) Hours 10.5 9.9 9.5
Calculated based on data from MEDIPAL HOLDINGS CORPORATION and consolidated subsidiaries
  • *1 As of March 31
  • *2 Calculated based on data from
    MEDIPAL HOLDINGS CORPORATION,
    MEDICEO CORPORATION,
    EVERLTH Co., Ltd.,
    ATOL CO., LTD.,
    MM CORPORATION,
    MEDISKET CORPORATION,
    PALTAC CORPORATION,
    MP AGRO CO., LTD.,
    MP Gokyo Food & Chemical Co., Ltd.,
    MEDIPAL FOODS CORPORATION

Governance

Overview of the Corporate Governance

Unit FY2022 FY2023 FY2024
Directors Number of Directors - 12 12 12
Number of outside directors - 4 4 4
Outside directors rate % 33.3 33.3 33.3
Number of female directors - 2 2 2
Female directors rate % 16.7 16.7 16.7
Audit & Supervisory Board members Number of Audit & Supervisory Board members - 5 5 5
Number of outside Audit & Supervisory Board members - 3 3 3
Outside Audit & Supervisory Board members rate % 60.0 60.0 60.0
Number of female Audit & Supervisory Board members - 1 1 1
Female Audit & Supervisory Board members rate % 20.0 20.0 20.0
Nomination Committee members Number of Nomination Committee members - 6 6 6
Number of outside directors - 4 4 4
Outside directors rate % 66.7 66.7 66.7
Compensation Committee members Number of Compensation Committee members - 6 6 6
Number of outside directors - 4 4 4
Outside directors rate % 66.7 66.7 66.7
Compliance Committee Number of Compliance Committee - 5 5 5
Number of outside directors - 2 2 2
Outside directors rate % 40.0 40.0 40.0

Meetings in the Fiscal Year Ended

Unit FY2022 FY2023 FY2024
Board of Directors Number of meetings Times 15 13 13
Attendance by outside directors % 95.0 92.3 96.2
Attendance by outside Audit & Supervisory Board members % 97.8 97.1 100
Audit & Supervisory Board Number of meetings Times 13 13 13
Attendance by outside Audit & Supervisory Board members % 97.4 100 100
Nomination Committee Number of meetings Times 6 3 4
Attendance by outside directors % 95.8 91.7 87.5
Compensation Committee Number of meetings Times 2 3 4
Attendance by outside directors % 100 91.7 87.5
Compliance Committee Number of meetings Times 4 4 4
Attendance by outside directors % 100 75.0 87.5

Status of Strategic Shareholdings

Unit FY2022 FY2023 FY2024
Strategic Shareholdings Number of issuers Issues 74 70 67
Total amount on balance sheet Millions of yen 96,725 100,881 95,416

Compensation for Directors

Unit FY2022 FY2023 FY2024
Total Amount of Compensation Directors (Number of Relevant Corporate Officers) Millions of yen（Persons） 264 (9) 255 (9) 281 (8)
Audit & Supervisory Board members (Number of Relevant Corporate Officers) Millions of yen (Persons) 48 (2) 46 (3) 45 (2)
Outside Directors (Number of Relevant Corporate Officers) Millions of yen (Persons) 57 (4) 57 (4) 57 (4)
Outside Audit & Supervisory Board members (Number of Relevant Corporate Officers) Millions of yen (Persons) 32 (3) 32 (4) 32 (3)
  • Calculated based on data from MEDIPAL HOLDINGS CORPORATION